POLY MEDICURE
|
POLY MEDICURE Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹453 Cr | ₹344 Cr | ₹237 Cr | ₹195 Cr | ₹180 Cr |
| Adjustment | ₹35 Cr | ₹37 Cr | ₹61 Cr | ₹39 Cr | ₹44 Cr |
| Changes In working Capital | ₹-154 Cr | ₹-41 Cr | ₹-49 Cr | ₹-63 Cr | ₹-61 Cr |
| Cash Flow after changes in Working Capital | ₹333 Cr | ₹340 Cr | ₹249 Cr | ₹171 Cr | ₹163 Cr |
| Cash Flow from Operating Activities | ₹240 Cr | ₹266 Cr | ₹191 Cr | ₹123 Cr | ₹119 Cr |
| Cash Flow from Investing Activities | ₹-1,194 Cr | ₹-241 Cr | ₹-179 Cr | ₹-85 Cr | ₹-436 Cr |
| Cash Flow from Financing Activities | ₹951 Cr | ₹-20 Cr | ₹-13 Cr | ₹-35 Cr | ₹317 Cr |
| Net Cash Inflow / Outflow | ₹-3.35 Cr | ₹4.99 Cr | ₹-0.70 Cr | ₹2.80 Cr | ₹0.10 Cr |
| Opening Cash & Cash Equivalents | ₹12 Cr | ₹7.06 Cr | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹8.70 Cr | ₹12 Cr | ₹7.06 Cr | ₹7.76 Cr | ₹4.95 Cr |
Compare Cashflow Statement of peers of POLY MEDICURE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| POLY MEDICURE | ₹18,076.6 Cr | -0.7% | -6.6% | -30.8% | Stock Analytics | |
| NURECA | ₹285.2 Cr | 0.1% | 11.9% | -0.1% | Stock Analytics | |
POLY MEDICURE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | -0.7% |
-6.6% |
-30.8% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses